Emergent BioSolutions (EBS) Net Equity Issued and Repurchased (2023 - 2026)
Emergent BioSolutions' (EBS) quarterly Net Equity Issued and Repurchased came in at $400000.0 in Q1 2026, up 140.0% quarter-over-quarter from -$1.0 million in Q4 2025.
Emergent BioSolutions (EBS) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends
Emergent BioSolutions' Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $400000.0 for Q1 2026.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $400000.0 in Q1 2026; TTM through Mar 2026 was -$600000.0, a 400.0% decrease from a year earlier, with the FY2023 full-year figure at $8.4 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased grew to $400000.0 in Q1 2026 per EBS's latest filing, from -$1.0 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $400000.0 in Q1 2026 and bottomed at -$1.0 million in Q4 2025.
- The 3-year median for Net Equity Issued and Repurchased is $200000.0 (2023), against an average of -$133333.3.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 500,000.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Emergent BioSolutions | 389.77 Mn | 228.27 Mn | 84.10 Mn | 400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 400,000.00 |
| Mar 31, 2026 | 400,000.00 |
| Dec 31, 2025 | -1.00 Mn |
| Dec 31, 2025 | -1.00 Mn |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |